The board of directors of Unitrin, who held 23% of the shares, did not think the price offered was adequate and so initiated a poison pill and offered a buyback to increase their holdings to 28% of the total shares.
The board of directors of Unitrin, who owned 23% of the shares, deemed the offered price inadequate and implemented a poison pill strategy to increase their ownership to 28%.